No Data
No Data
Biology Co., Ltd. (600201.SH): Jointly established “Inner Mongolia Centennial Synthetic Biotechnology Co., Ltd.” with leading domestic research teams
Gelonghui, May 9 | Biotech Co., Ltd. (600201.SH) said on the interactive platform that in 2023, the company will “take the lead in entering the era of innovative synthetic biology integrating biotechnology and information technology; advance into multiple multivalent vaccines, iterative vaccines, digital vaccines and novel drugs to overcome the 100-year challenge of the African swine fever vaccine; apply AI intelligence to provide the aquaculture industry with overall solutions for epidemic prevention and control, and use value marketing to improve quality and efficiency for users” as the company's development strategy. As a path support for achieving strategic goals, the company and leading domestic research teams jointly established “Inner Mongolia Centennial Synthetic Biotechnology Co., Ltd.” This creation
Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Just Slashed This Year's Estimates
The analysts covering Jinyu Bio-technology Co., Ltd. (SHSE:600201) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year.
Biotech Co., Ltd. (600201.SH) announced first-quarter results, net profit of 106 million yuan decreased by 1.05% year-on-year
Biotech Co., Ltd. (600201.SH) released its report for the first quarter of 2024. The company achieved operating income of 3 during the reporting period...
Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Business Is Trailing The Market But Its Shares Aren't
With a price-to-earnings (or "P/E") ratio of 33.3x Jinyu Bio-technology Co., Ltd. (SHSE:600201) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E
Is The Market Rewarding Jinyu Bio-technology Co., Ltd. (SHSE:600201) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
With its stock down 14% over the past three months, it is easy to disregard Jinyu Bio-technology (SHSE:600201). It is possible that the markets have ignored the company's differing financials and de
Calculating The Intrinsic Value Of Jinyu Bio-technology Co., Ltd. (SHSE:600201)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Jinyu Bio-technology fair value estimate is CN¥6.57 With CN¥7.71 share price, Jinyu Bio-technology appears to be trading close to its estimat
No Data